SERIES [A/B/C] COMMON STOCK PURCHASE WARRANT rENNOVA HEALTH, INC.Security Agreement • March 27th, 2017 • Rennova Health, Inc. • Services-testing laboratories
Contract Type FiledMarch 27th, 2017 Company IndustryTHIS SERIES [A/B/C] COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the _____[2] year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Rennova Health, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock [;provided, however, the exercisability of this Series C Warrant shall vest ratably from time to time in proportion to the Holder’s (or its permitted assigns) exercise of the Series B Common Stock Purchase Warrant as compared with all Series B Common Stock Purchase Warrants issued to Holder at the Closing (“Vesting Schedule”). No
SECURITY AGREEMENTSecurity Agreement • March 27th, 2017 • Rennova Health, Inc. • Services-testing laboratories • Nevada
Contract Type FiledMarch 27th, 2017 Company Industry JurisdictionThis SECURITY AGREEMENT (the “Agreement”) is made as of March 20, 2017, is executed by and between RENNOVA HEALTH, INC., a corporation incorporated under the laws of the State of Delaware (the “Grantor”), and TCA GLOBAL CREDIT MASTER FUND, LP, a limited partnership organized and existing under the laws of the Cayman Islands (the “Secured Party”).
GUARANTY AGREEMENTGuaranty Agreement • March 27th, 2017 • Rennova Health, Inc. • Services-testing laboratories • Nevada
Contract Type FiledMarch 27th, 2017 Company Industry JurisdictionThis GUARANTY AGREEMENT is dated as of March 20, 2017 (as amended, restated or modified from time to time, the “Guaranty”), and is made by RENNOVA HEALTH, INC., a corporation incorporated under the laws of the State of Delaware (the “Guarantor”), in favor of TCA GLOBAL CREDIT MASTER FUND, LP, a limited partnership organized and existing under the laws of the Cayman Islands (the “Buyer”).
March 20, 2017 Seamus Lagan, CEO Rennova Health, Inc. Suite 800 West Palm Beach FL 33401Investment Banking Services Agreement • March 27th, 2017 • Rennova Health, Inc. • Services-testing laboratories • Nevada
Contract Type FiledMarch 27th, 2017 Company Industry JurisdictionThis agreement by and between TCA Global Credit Master Fund, LP (“TCA”) and Rennova Health, Inc. (hereinafter collectively known as the “Company”) is dated March 20, 2017 and encompasses the following advisory services to be provided by TCA to the Company (the “Agreement”).
INTERCREDITOR AGREEMENTIntercreditor Agreement • March 27th, 2017 • Rennova Health, Inc. • Services-testing laboratories • Nevada
Contract Type FiledMarch 27th, 2017 Company Industry JurisdictionThis INTERCREDITOR AGREEMENT (the “Agreement”) is dated March 20, 2017, by and between SABBY MANAGEMENT, LLC, a limited liability company organized and existing under the laws of the State of Delaware (“Sabby Management”), acting on behalf and for the benefit of SABBY HEALTHCARE MASTER FUND, LTD, SABBY VOLATILITY WARRANT MASTER FUND LTD, and LINCOLN PARK CAPITAL FUND, LLC (together the “New Lenders”) and TCA GLOBAL CREDIT MASTER FUND, LP, a limited partnership organized and existing under the laws of the Cayman Islands (“TCA” and together with Sabby Management, the “Creditors” and each a “Creditor”).
Re. Securities Purchase Agreement, dated as of May 31, 2015, as amendedSecurities Purchase Agreement • March 27th, 2017 • Rennova Health, Inc. • Services-testing laboratories • Nevada
Contract Type FiledMarch 27th, 2017 Company Industry JurisdictionReference is hereby made to that certain Securities Purchase Agreement, dated as of May 31, 2015 (as amended and as may hereafter be amended or restated from time to time, the “Purchase Agreement”), made by and among: (i) Medytox Solutions, Inc. (the “Company”), (ii) Health Technology Solutions, Inc., a corporation incorporated under the laws of the State of Florida, Medytox Institute of Laboratory Medicine, Inc., a corporation incorporated under the laws of the State of Florida, Medical Billing Choices Inc., a corporation incorporated under the laws of the State of North Carolina, Medytox Diagnostics, Inc., a corporation incorporated under the laws of the State of Florida, Medytox Medical Marketing & Sales, Inc., a corporation incorporated under the laws of the State of Florida, PB Laboratories, LLC, a limited liability company organized and existing under the laws of the State of Florida, Biohealth Medical Laboratory Inc., a corporation incorporated under the laws of the State of Flo